In particular, RCN1 was implicated in the regulation of drug resistance, and RCN1 knockdown was found to reduce the resistance of nasopharyngeal carcinoma (NPC) cells/tissues to doxorubicin, promoting NPC cell death [21]. Here, RCN1 is linked to nasopharyngeal carcinoma.